• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW DIMENSION VISTA®; DIMENSION VISTA® SYSTEM 500

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW DIMENSION VISTA®; DIMENSION VISTA® SYSTEM 500 Back to Search Results
Model Number DIMENSION VISTA 500 DOMESTIC
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/26/2017
Event Type  malfunction  
Manufacturer Narrative
The customer called into the siemens customer care center reporting falsely depressed serum results.The issue was identified as a user error.On january 26, 2017 the customer had incorrectly changed the serum potassium method comparison coefficients instead of the urine method comparison coefficients on the dimension vista® 500 intelligent lab system, after receiving customer notification vc-17-01.A.Us, dated december 19, 2016.The issue was detected by qc and patient serum k samples were run while the incorrect method comparison coefficients were entered.The customer notification instructed customers that siemens healthcare diagnostics has confirmed a low bias for dimension vista v-lyte integrated multisensor urine potassium (k) when compared to the dimension quiklyte® integrated multisensor, which is the predicate device used in the method comparison section of the v-lyte instructions for use (ifu).This bias affects patient results and qc and could result in failures in accuracy-based proficiency testing programs.The customer notification instructed the customer to change the method comparison coefficients for urine potassium only to compensate for this bias, and new method comparison coefficients were provided.The instructions stated that the correlation factors should be applied to the urine sample type only and emphasized that serum potassium results are not affected by this issue as there are separate parameters for serum potassium.The customer notification provided illustrations of the proper installation of the urine potassium coefficients within the method configuration screen.In this instance, the customer entered the c0 and c1 coefficient values provided into the serum potassium method configuration rather than for the urine potassium method configuration.This error caused the falsely depressed results obtained for serum samples.In this instance, patient samples were not run prior to running qc which detected the error.The issue was resolved by the customer correcting the coefficient values for serum and properly entering the urine coefficients.A customer notification follow up information vc-17-01.B.Us dated january 26, 2017 was sent to customers to reinforce the instructions of the original customer notification.It stated: "siemens has learned that there have been reports of customers inadvertently entering the method comparison coefficients indicated for urine potassium into the serum or plasma potassium tab.Siemens healthcare diagnostics is issuing this customer notification with enhanced instructions for updating and verifying the urine potassium method comparison coefficients.Please follow the enhanced instructions below even if you have already updated the urine potassium coefficients provided in the previous customer notification, vc-17-01.A.Us.The serum and plasma potassium comparison coefficients should not be changed on your system." the customer stated the dates they received the notifications vc-17-01.A.Us on 1/26/17 and vc-17-01.B.Us on 1/27/17.Siemens has confirmed that the customer was on the original mailing list for the first customer notification vc-17-01.A.Us.The instrument is performing within specifications.No further evaluation of the device is required.
 
Event Description
Discordant, falsely depressed serum potassium (k) results were obtained on qc and patient samples on the dimension vista 500 system.Patient results were reported to physicians.Once the low qc was detected, an error in the entry of method comparison correlation factors was corrected.Corrected results were reported.There are no reports of patient intervention or adverse health consequences due to the discordant, falsely depressed serum potassium results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DIMENSION VISTA®
Type of Device
DIMENSION VISTA® SYSTEM 500
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW
glasgow business community
500 gbc drive po box 6101
newark DE 19714 6101
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS INC- BROOKFIELD
registration number 1226181
101 silvermine road
brookfield CT 06804
Manufacturer Contact
james morgera
glasgow business community
500 gbc drive po box 6101
newark, DE 19714-6101
3026318356
MDR Report Key6354640
MDR Text Key68280887
Report Number2517506-2017-00128
Device Sequence Number0
Product Code CEM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K051087
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Health Professional
Remedial Action Recall
Type of Report Initial
Report Date 02/23/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberDIMENSION VISTA 500 DOMESTIC
Device Catalogue NumberSMN 10284473
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/27/2017
Initial Date FDA Received02/23/2017
Was Device Evaluated by Manufacturer? No
Date Device Manufactured06/22/2011
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-